X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

CPHI Japan 2024: Rising Tides manufacturing in Japan

Content Team by Content Team
14th March 2024
in Middle East and South Asia, News
CPHI Japan 2024: Rising Tides manufacturing in Japan

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

CPHI Japan 2024 (17-19 April) will see a 20+% year-on-year rise, with a record attendance of an expected 20,000 attendees as the country undergoes a post pandemic boom in pharma – with biologics and tides manufacturing expected to grow quickly.

The event is widely seen as a barometer of overall health in the country’s pharma industry and in light of significant R&D growth, Tides will collaborate with CPHI Japan to introduce a free conference. The increased interest is attributed to a proactive regulatory framework and the country’s strong base of peptide and oligonucleotide chemistry and synthesis. Prof Hiroaki Suga of the University of Tokyo will present his predictions on the potential of mRNA and peptides at the event.

The new Tides conference explores the country’s expanding role in the development of ‘Next Generation Cyclic Peptide Drug Discovery’. These are among the most diverse architectures for current drug discovery efforts, and are modulating some of the most challenging targets, including protein–protein interactions and those considered to be ‘undruggable’.

In a further boon to attendees, Mr. Kiyoto Nakai, Director of the Drug Evaluation and Control Division at the Pharmaceutical Affairs Bureau of the Ministry of Health, Labor, and Welfare, will provide a keynote address on recent regulatory changes. Additionally, the Japan Pharmaceutical Manufacturers Association (JPMA) will outline the implications for Japanese manufactures of recent updates ICH Quality Guidelines.

“The 2024 event promises to be the largest in our history with nearly 4000 additional attendees expected compared to last year. What’s behind this surge? well the industry in Japan is innovating incredibly quickly and we see new capabilities in tides manufacturing as well as demand for improved stability and flexibility in API networks across Asia – so the International Procurement Forum for APIs hosted by the Japan Pharmaceutical Traders Association is another key highlight,” commented Jenny Leung, brand manager at CPHI Japan.

In addition to the keynote speeches and over 200 seminars, CPHI Japan will span the entire pharmaceutical supply chain as country’s largest pharma exhibition, with more than 680 exhibitors across five dedicated zones (Ingredients, Outsourcing, biopharma, Machinery & Equipment, and DDS & Packaging). In total some 50+ countries will be represented with dedicated pavilions for China, Korea, Italy as well as for the Japan Pavilion by Japan Bulk Pharmaceutical Manufacturing Association (JBPMA), and the Japan Pharmaceutical Excipients Council Pavilion.

Leung added: “Japanese pharma companies are rapidly internationalising their supply chains and the growth we have seen in 2024 is a direct result of this demand for greater partnering – with improved supply chain stability a major consideration. The other notable trend has been the acceleration of innovation and we are seeing a cross pollination for trends driving in recent years, with increasing numbers of international exhibitors and attendees at the event. In particular, many companies are looking for new partners for outsourced manufacturing and API procurement.

Previous Post

FDA Finally Gives Nod To DxFLEX Clinical Flow Cytometer

Next Post

The Role of Warehouse Management In Pharmaceutical Sector

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post

The Role of Warehouse Management In Pharmaceutical Sector

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In